Borkar Durga S, Homayounfar Gelareh, Tham Vivien M, Ray Kathryn J, Vinoya Aleli C, Uchida Aileen, Acharya Nisha R
F. I. Proctor Foundation, University of California-San Francisco2Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston.
F. I. Proctor Foundation, University of California-San Francisco.
JAMA Ophthalmol. 2017 Jun 1;135(6):594-599. doi: 10.1001/jamaophthalmol.2017.1009.
Common pathophysiological mechanisms may be responsible for immune dysregulation in both thyroid disease and uveitis. Studies investigating a possible association are limited.
To determine the association between thyroid disease and uveitis.
DESIGN, SETTING, AND PARTICIPANTS: A retrospective, population-based case-control study was conducted from January 1, 2006, to December 31, 2007, among 217 061 members of the Kaiser Permanente Hawaii health system during the study period. A clinical diagnosis of uveitis was determined through a query of the electronic medical record followed by individual medical record review for confirmation by a uveitis specialist. Thyroid disease was determined based on International Classification of Diseases, Ninth Revision, coding. Two control groups were chosen at a 4:1 ratio for comparison with patients with uveitis. A logistic regression analysis was performed with uveitis as the main outcome variable and thyroid disease as the main predictor variable, while adjusting for age, sex, race, smoking status, and history of autoimmune disease. Data analysis was conducted between 2014 and 2016.
A diagnosis of thyroid disease among patients with uveitis and respective controls.
Of the 224 patients with uveitis (127 women and 97 men; mean [SD] age, 54.1 [17.8] years) identified during the study period, 29 (12.9%) had a diagnosis of thyroid disease, compared with 62 of 896 patients (6.9%) in the control group (P = .01) and 78 of 896 patients (8.7%) in the ophthalmology clinic control group (P = .06). Using the general Kaiser Permanente Hawaii population control group, patients who had thyroid disease had a 1.7-fold (95% CI, 1.03-2.80; P = .04) higher odds of having uveitis compared with patients who did not have thyroid disease when controlling for age, sex, race, smoking status, and autoimmune disease. A similar association was found using the ophthalmology clinic control group (odds ratio, 1.8; 95% CI, 1.1-2.9; P = .02) while adjusting for these factors.
These findings suggest that a history of thyroid disease has a weak to moderate association with uveitis. Similar autoimmune mechanisms could explain the pathogenesis of both conditions. If future studies corroborate these findings, they may have further clinical implications in the laboratory workup of uveitis.
常见的病理生理机制可能是甲状腺疾病和葡萄膜炎免疫失调的原因。关于二者可能存在关联的研究有限。
确定甲状腺疾病与葡萄膜炎之间的关联。
设计、背景和参与者:本研究为一项基于人群的回顾性病例对照研究,研究对象为2006年1月1日至2007年12月31日期间夏威夷凯撒医疗集团健康系统的217061名成员。通过查询电子病历并由葡萄膜炎专科医生进行个人病历审查来确诊葡萄膜炎。甲状腺疾病根据《国际疾病分类第九版》编码确定。以4:1的比例选择两个对照组与葡萄膜炎患者进行比较。以葡萄膜炎作为主要结局变量,甲状腺疾病作为主要预测变量进行逻辑回归分析,同时对年龄、性别、种族、吸烟状况和自身免疫性疾病史进行校正。数据分析于2014年至2016年进行。
葡萄膜炎患者及相应对照组中甲状腺疾病的诊断情况。
在研究期间确定的224例葡萄膜炎患者(127例女性和97例男性;平均[标准差]年龄为54.1[17.8]岁)中,29例(12.9%)被诊断为甲状腺疾病,而对照组896例患者中有62例(6.9%)(P = 0.01),眼科门诊对照组896例患者中有78例(8.7%)(P = 0.06)。在控制年龄、性别、种族、吸烟状况和自身免疫性疾病的情况下,与无甲状腺疾病的患者相比,患有甲状腺疾病的患者发生葡萄膜炎的几率高1.7倍(95%可信区间,1.03 - 2.80;P = 0.04)。使用眼科门诊对照组进行这些因素校正时,也发现了类似的关联(优势比,1.8;95%可信区间,1.1 - 2.9;P = 0.02)。
这些发现表明,甲状腺疾病史与葡萄膜炎之间存在弱至中度关联。相似的自身免疫机制可能解释这两种疾病的发病机制。如果未来的研究证实这些发现,它们可能对葡萄膜炎的实验室检查有进一步的临床意义。